This article focuses on the work of the National Institute of Neurological Disorders and Stroke (NINDS) and other institutes within the NIH in the United States, which are at the forefront of research on multiple sclerosis (MS). These institutions are heavily involved in brain and nervous system research, providing significant resources for MS studies. Although the exact cause of MS remains elusive, there has been substantial progress in other areas, particularly in developing new treatments to prevent disease flare-ups.
The research encompasses a variety of topics including biomarkers for MS diagnosis and monitoring disease progression, genetic and environmental risk factors, the role of gut microbiome and diet, gender differences in MS incidence and presentation, and disparities in care across different ethnic groups. The basic functions of myelination, demyelination, axonal degeneration, and strategies to counteract axonal and myelin loss are also being studied.
Scientists supported by NIAID are testing an experimental stem cell treatment known as autologous hematopoietic stem cell transplantation (AHSCT) against top biologic therapies for severe forms of relapsing MS. Additionally, genetic research is focusing on ‘susceptibility genes’ linked to an increased risk of MS, with several candidate genes under investigation.
Efforts are also underway to develop enhanced neuroimaging tools, such as advanced MRI techniques, to diagnose MS, track its progression, and evaluate treatments. NINDS researchers are utilizing MRI to study the natural history of MS and the mechanisms and side effects of disease-modifying therapies.
Overall, NIH is concentrating on developing therapies to halt or reverse MS progression, with a focus on immune system modification, myelin repair, or neuronal protection. There is also an increased focus on understanding and treating progressive MS. In addition, significant work is being done to develop effective biomarkers for MS, with studies on rapid MRI approaches and blood tests measuring neuron-derived proteins.”
This summary captures the essence of the original article, highlighting the extensive and ongoing research efforts to understand and treat multiple sclerosis.
You can reach the full article from here.
hello there and thank you for your info ? I’ve certainly picked up something new from right here.Anyway Iadding this RSS to my e-mail and could look out for a lot more of your respective fascinating content. Make sure you update this again soon..
Thank you so much for your comment. 🙂
I ‘m fairly certain that you are correct with this.